MX2007000084A - Formas solidas de linezolid y procesos para la preparacion delas mismas. - Google Patents

Formas solidas de linezolid y procesos para la preparacion delas mismas.

Info

Publication number
MX2007000084A
MX2007000084A MX2007000084A MX2007000084A MX2007000084A MX 2007000084 A MX2007000084 A MX 2007000084A MX 2007000084 A MX2007000084 A MX 2007000084A MX 2007000084 A MX2007000084 A MX 2007000084A MX 2007000084 A MX2007000084 A MX 2007000084A
Authority
MX
Mexico
Prior art keywords
crystalline forms
novel crystalline
linezolid
processes
preparation
Prior art date
Application number
MX2007000084A
Other languages
English (en)
Inventor
Judith Aronhime
Tamas Koltai
Viviana Braude
Serguei Fine
Tamar Niddam
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of MX2007000084A publication Critical patent/MX2007000084A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Se revelan formas cristalinas novedosas de Linezolid, designadas como Forma TIII, Forma V, Forma VI, Forma IX, Forma X, Forma XII, Forma XIV, Forma VII, y Forma XVIII. Las formas cristalinas novedosas se caracterizan mediante difraccion de rayos X de polvo, espectroscopia de FTIR y de FTRaman y calorimetria de exploracion diferencial. Tambien se describen metodos de preparacion de las formas cristalinas novedosas, composiciones farmaceuticas que comprenden las formas cristalinas novedosas y metodos de uso de las formas cristalinas novedosas para tratar infecciones bacterianas grampositivas. Tambien se revela linezolid amorfo.
MX2007000084A 2004-06-29 2005-06-29 Formas solidas de linezolid y procesos para la preparacion delas mismas. MX2007000084A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US58437104P 2004-06-29 2004-06-29
US58428304P 2004-06-30 2004-06-30
US60108604P 2004-08-12 2004-08-12
US60222704P 2004-08-17 2004-08-17
US63388704P 2004-12-07 2004-12-07
US67844005P 2005-05-05 2005-05-05
US68441005P 2005-05-24 2005-05-24
PCT/US2005/023066 WO2006110155A1 (en) 2004-06-29 2005-06-29 Solid forms of linezolid and processes for preparation thereof

Publications (1)

Publication Number Publication Date
MX2007000084A true MX2007000084A (es) 2007-06-14

Family

ID=37649359

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007000084A MX2007000084A (es) 2004-06-29 2005-06-29 Formas solidas de linezolid y procesos para la preparacion delas mismas.

Country Status (7)

Country Link
US (1) US20060111350A1 (es)
EP (1) EP1745028A2 (es)
JP (1) JP2008501619A (es)
CA (1) CA2572207A1 (es)
IL (1) IL180359A0 (es)
MX (1) MX2007000084A (es)
WO (1) WO2006110155A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002059214A1 (en) * 2001-01-26 2002-08-01 Nippon Shokubai Co., Ltd. Water absorbing agent and method for production thereof, and water absorbing article
EP1677736A4 (en) * 2003-10-28 2007-09-12 Spi Pharma Inc PRODUCT AND PROCESS FOR INCREASING COMPACTION ABILITY FOR CARBOHYDRATES
US20070092562A1 (en) * 2003-10-28 2007-04-26 Spi Pharma, Inc. Product and process for increasing compactibility of carbohydrates
EP1866295A2 (en) * 2005-02-24 2007-12-19 Teva Pharmaceutical Industries Ltd Processes for the preparation of linezolid intermediate
EP2033960A3 (en) 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Linezolid crystalline hydrate form and linezolid salts
WO2009063505A2 (en) * 2007-10-08 2009-05-22 Usv Limited Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide
ITMI20072359A1 (it) * 2007-12-18 2009-06-19 Dipharma Francis Srl Procedimento per la preparazione di derivati ossazolidinonici
WO2009140466A2 (en) * 2008-05-14 2009-11-19 Dr. Reddy's Laboratories Ltd. Linezolid co-crystals
WO2011050826A1 (en) * 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
EP2496563A4 (en) * 2009-11-04 2013-04-03 Sichuan Beilike Biotechnology Ltd Liability Company CRYSTALLINE HYDRATES, THEIR PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREPARATION AND USE
CN102174027B (zh) * 2010-03-11 2014-04-02 四川美大康佳乐药业有限公司 利奈唑胺的新晶型及其制备方法和用途
EP2603505A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
EP2603506A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
US9132132B2 (en) 2010-09-02 2015-09-15 Hetero Research Foundation Pharmaceutical compositions of linezolid
WO2012119653A1 (en) 2011-03-09 2012-09-13 Synthon Bv Process for making crystalline form a of linezolid
CN102260222B (zh) * 2011-05-20 2015-05-13 上海医药工业研究院 利奈唑胺晶型v及其制备方法
WO2013072923A1 (en) * 2011-09-19 2013-05-23 Cadila Healthcare Limited Process for the preparation of crystalline linezolid
CN102675239A (zh) * 2012-06-06 2012-09-19 开原亨泰制药股份有限公司 一种制备利奈唑酮晶型i的方法
WO2014013498A1 (en) * 2012-07-17 2014-01-23 Symed Labs Limited Amorphous coprecipitates of linezolid
ES2603252T3 (es) 2012-11-09 2017-02-24 Synthon Bv Proceso para preparar linezolid
WO2014118809A1 (en) 2013-01-29 2014-08-07 Actavis Group Ptc Ehf. Pharmaceutical composition with linezolid
CN103483294B (zh) * 2013-08-12 2015-01-28 四川大学 3-氨基-2-丙醇乙酰胺类化合物的盐、其制备方法和用途
IN2013MU03508A (es) 2013-11-06 2015-07-24 Unimark Remedies Ltd
CN105503764B (zh) * 2016-01-12 2017-09-19 江苏豪森药业集团有限公司 利奈唑胺晶型b及其制备方法和用途
US20190343761A1 (en) 2016-11-16 2019-11-14 Persica Pharmaceuticals Ltd. Antibiotic formulations for lower back pain
PL3709970T3 (pl) 2017-11-16 2025-09-08 Persica Pharmaceuticals Ltd. Preparaty linezolidu
JP2024537142A (ja) 2021-10-12 2024-10-10 ペルシカ ファーマシューティカルズ リミテッド 腰痛治療

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
US6444813B2 (en) * 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AR027261A1 (es) * 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
AU2003278592A1 (en) * 2003-10-16 2005-04-27 Symed Labs Limited A novel crystalline form of linezolid

Also Published As

Publication number Publication date
WO2006110155A8 (en) 2006-11-30
US20060111350A1 (en) 2006-05-25
EP1745028A2 (en) 2007-01-24
IL180359A0 (en) 2007-06-03
JP2008501619A (ja) 2008-01-24
WO2006110155A1 (en) 2006-10-19
WO2006110155B1 (en) 2007-01-18
CA2572207A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
MX2007000084A (es) Formas solidas de linezolid y procesos para la preparacion delas mismas.
NZ601738A (en) Apixaban formulations
ATE495747T1 (de) Kristalline form des ibandronat-natriums und herstellungsverfahren dafür
MXPA01006474A (es) Derivados colquinol como agentes perjudiciales vasculares.
TNSN07164A1 (en) Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
WO2011048604A3 (en) Processes for the preparation of darunavir and the amorphous form thereof
TW200736258A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
EP1732384A4 (en) NOVEL SYNTHETIC C-GLYCOLIPIDES, THEIR SYNTHESIS AND USE FOR THE TREATMENT OF INFECTIONS, CANCER AND AUTOIMMUNE DISEASES
YU95102A (sh) Supstituisani biciklični derivati u lečenju abnormalnog rasta ćelija
MY139399A (en) Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
TNSN08070A1 (en) Benzoquinazoline derivatives and their use in treating bone disorders
TN2012000362A1 (en) Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
NZ601347A (en) Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
MX2007000044A (es) Compuestos, composiciones y metodos de tetrahidroquinazolin-4(3h)- ona-relacionados y tetrahidropirido [2,3-d] pirimidin-4(3h)-ona- relacionados para su uso.
WO2006004922B1 (en) Crystalline form iv of linezolid
RU2007141198A (ru) Кристаллическая форма малеата азенапина
NZ595903A (en) A novel formulation of metaxalone
PL1989174T3 (pl) Podstawione pochodne cykloheksylometylu
TW200624432A (en) Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto
WO2023192961A3 (en) Ligand-payload conjugates
WO2007125398A3 (en) : sulfonamide compounds as antagonists of the n-type calcium channel
MXPA04000779A (es) 7-aza[2.2.1]bicicloheptanos sustituidos con arilo para el tratamiento de enfermedades.
WO2006026204A3 (en) Novel gamma-lactams as beta-secretase inhibitors
GB0428416D0 (en) Organic compounds
TNSN02096A1 (en) Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth